EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GCF-anchored and target-oriented mining of metagenomic BGC space for bioactive product discovery

Xiao Yang, Jiacheng Wu iD, Tao Wang, Ziyun Li, Yaxuan Xi, Lanlan Zhao, Mingjing Luo, Xiuxiu Xie, Guoping Zhao iD, Haokui Zhou iD, Lei Zhang iD

Microbiology Spectrum · 03.11.2026 · 14 (11)

DOI: 10.1128/spectrum.01098-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 03.11.2026. Verfasst von Xiao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Biological Products, Multigene Family, Metagenomics, Drug Discovery. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbial natural products are vital for drug discovery, yet pervasive genomic fragmentation and data volume hinder the translation of metagenomic biosynthetic gene clusters (BGCs) into therapeutic leads. We present metasynBGC , a target-oriented framework that employs a “function-first” logic using experimentally validated gene cluster families (GCFs) as evolutionary templates and functional beacons. This dual-path strategy enables (i) template-guided reconstruction of fragmented BGCs via conserved biosynthetic synteny, and (ii) high-resolution prioritization of complete BGCs based on therapeutic potential. Applying metasynBGC to large-scale public metagenome-assembled genome (MAG) data sets, we uncovered hidden biosynthetic potential, including BGC0001089_plus, a novel bacillaene-like variant containing an additional functional pksF gene. Simultaneously, bioactivity-prioritized mining of nonribosomal peptide synthetase (NRPS) BGCs, coupled with deep learning and chemical synthesis, yielded six novel compounds. These molecules exhibited diverse in vitro cytotoxic profiles across seven cancer cell lines, with I C 50 values as low as 38.04 µM. Compounds D and E showed potent activity and pronounced cell-line selectivity. By transforming microbial “dark matter” into an actionable reservoir of therapeutic leads, metasynBGC provides a practical target-oriented strategy for linking metagenomic BGC mining with downstream experimental validation. The scripts used in this study are publicly available at https://github.com/Shirly-Yang/metasynBGC . IMPORTANCE The vast chemical diversity hidden within metagenomic data remains largely inaccessible because biosynthetic gene clusters (BGCs) are often highly fragmented. Our study introduces metasynBGC , a target-oriented framework designed to bridge these gaps by using well-characterized BGCs within gene cluster families (GCFs) as templates to reconstruct incomplete biosynthetic pathways. Unlike traditional methods, metasynBGC integrates a dual-path discovery engine: it performs priority-driven mining to precisely locate naturally intact clusters while reconstructing fragmented ones using representative BGC members as guides. We demonstrate its efficacy by identifying and synthesizing novel compounds with notable cytotoxic activity, providing a validated “sequence-to-molecule” pipeline. This work offers a scalable framework for the systematic discovery of therapeutic candidates from uncultivated microbes and expands our capacity to interpret genomic “dark matter.” By enabling the functional validation of complex molecules from fragmented data, metasynBGC facilitates the translation of metagenomic data sets into promising leads for therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biological ProductsMultigene FamilyMetagenomicsDrug DiscoveryBacteriaHumansBiosynthetic PathwaysMetagenomeData MiningPeptide Synthases

Stichwörter der Autor:innen

bioactive product discoverybiosynthetic gene clusters (BGCs)genome mining frameworkmetagenomicsnatural products

Substanzen

Biological ProductsPeptide Synthasesnon-ribosomal peptide synthase

Autor:innen und Institutionen

  • Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • State Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
  • School of Pharmaceutical Engineering, Jining Medical University, Jining, China.

ORCID-Profile: Jiacheng Wu, Guoping Zhao, Haokui Zhou, Lei Zhang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, X., Wu, J., Wang, T., Li, Z., Xi, Y., Zhao, L., Luo, M., Xie, X., Zhao, G., Zhou, H., & Zhang, L. (2026). GCF-anchored and target-oriented mining of metagenomic BGC space for bioactive product discovery. Microbiology Spectrum, 14(11). https://doi.org/10.1128/spectrum.01098-26

Vancouver

Yang X, Wu J, Wang T, Li Z, Xi Y, Zhao L, et al. GCF-anchored and target-oriented mining of metagenomic BGC space for bioactive product discovery. Microbiology Spectrum. 2026;14(11). doi:10.1128/spectrum.01098-26

BibTeX
@article{Yang2026,
  author = {Yang, Xiao and Wu, Jiacheng and Wang, Tao and Li, Ziyun and Xi, Yaxuan and Zhao, Lanlan and Luo, Mingjing and Xie, Xiuxiu and Zhao, Guoping and Zhou, Haokui and Zhang, Lei},
  title = {GCF-anchored and target-oriented mining of metagenomic BGC space for bioactive product discovery},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {11},
  doi = {10.1128/spectrum.01098-26}
}
Kostenlos starten →